“Tell me the percentage and the pH. I’ll decide.”
- Trigger
- A breakout; a routine reset
- Hesitation
- Vague claims; hidden concentrations
- Buys through
- Beauty marketplaces, D2C site
- What wins them
- Published concentrations, honest limits, a proof page
Brand template · Single-Active Skincare · India
Quiet confidence, visible proof.
A fictional brand, built by Maer Media as a brand-building template for India. Market observations are qualitative; every number on this page is a plan target, not a result.
01 · Market analysis
A skincare brand built on one active per product, published concentrations and a dermatologist panel, entering shelves where every bottle promises everything loudly.
Ingredient literacy has grown fast; buyers compare actives, concentrations and pH in comments and reviews.
Beauty marketplaces and quick commerce now sit beside D2C sites, so a serious formulation needs to stand out in a crowded grid.
Expert and dermatologist voices shape consideration more than celebrity endorsement.
Overclaiming has made buyers sceptical; brands that admit limits are increasingly the ones trusted.
A clinical brand that shows its evidence more prominently than its promises, and limits each product to one job done well.
02 · Customer mindset
Ingredient-literate 24 to 40-year-olds who read the back of the bottle, distrust hype and buy fewer products that work.
“Tell me the percentage and the pH. I’ll decide.”
“I have twelve products and no idea which ones work.”
03 · Brand system
For people who read the back of the bottle, Veil is skincare that lets the formulation do the talking: one active, one concentration, one proof.
Veil suggests something light that protects. It sounds calm, which is the point in a loud category.
A light precise grotesk in two weights, with concentrations set large in mono.
The seam: a single hairline that divides every pack, page and post into claim above and proof below.
5% niacinamide. Results in 4–8 weeks.
Not for active acne. See a dermatologist.
Refill, don’t rebuy.
Miracle glow in 3 days!
Clinically proven to change your life.
Flawless skin, guaranteed.
04 · The experience
Pick the concern you care about most. Veil recommends at most three products, never a twelve-step shelf.
Barrier serum at night, Daily SPF in the morning. Nothing else until skin settles.
Illustrative · fictional brand
05 · Lab to routine
Each product follows the same path from formulation to the customer’s fourth week, and each step is documented on the proof page.
One active at a set concentration, with stability tested.
Patch and in-use tests with a dermatology panel.
Concentration, pH and limits on the proof page.
Frosted bottle, seam carton, refill pouch.
A finder that recommends at most three products.
Week 4 and week 8 messages, with honest next steps.
06 · Go-to-market
Planned revenue mix at month six · target
Proof pages live, a dermatologist panel announced, and 20 explainer creators seeded.
A campaign inviting customers to compare labels, with disclosed explainers.
Routine finder, starter kit and refill pouches across platforms.
07 · Social growth pipeline
Three explainer Reels a week, one ingredient deep-dive a fortnight, and monthly results from the four-week check-ins.
One ingredient, explained.
Tests, limits and timelines.
Fewer products, used well.
Real skin, unretouched.
Expert explainers
800k monthly reachSaves on ingredient posts
5% save rateRoutine finder completions
20,000 a quarterStarter routine purchase
3.5% conversionRefill within 60 days
40% of buyersMonth-six targets. Illustrative, and set against a real baseline once live.
08 · Six-month targets
Starter to refill
Routine finder to order
On efficacy, not packaging
Clear fit before purchase
09 · Risks and rules in India
Registered under the Drugs and Cosmetics rules and labelled to BIS cosmetic standards.
No drug-like claims; percentages and results backed by tests.
ASCI disclosure on every paid or gifted post.
No retouched skin in any before-and-after content.
Category intelligence
Real-world precedents · from the journal
Start a conversation
If the product is worth building, the market around it deserves the same level of thought.